For 20 years, Truffle Capital has been financing innovation, developing and supporting pioneering technologies in the fields of healthcare and finance.
For more than two decades, Truffle Capital has been a leading independent European VC, at the forefront of financing and nurturing innovation, playing a pivotal role in the growth and empowerment of technology leaders in two fields of expertise: Life Sciences (MedTech, Biotech & BioEcoTech) and Deeptech applied to Finance (Fintech & Insurtech).
Truffle Capital's mission is to drive the creation and development of companies on their journey to becoming tomorrow's leaders in healthcare and Finance/Insurance. Led by its two co-founders and CEOs, Dr. Philippe Pouletty and Bernard-Louis Roques, Truffle Capital has €500M AuM, raising more than €1.2 Bn since its creation and supporting more than 120 companies with numerous successful exits. In line with its DNA, Truffle acts as a lead investor in financing rounds and is proactive in terms of governance.
